Bioequivalence Study of Cabergoline Tablets and Dostinex Under Fasting Conditions
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-04-04
- Last Posted Date
- 2008-04-04
- Lead Sponsor
- Par Pharmaceutical, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT00653055
- Locations
- ๐จ๐ฆ
Anapharm, Inc., Sainte-Foy, Quebec, Canada
Bioavailability Study of (Buspar) Buspirone HCl Tablets Under Fasting Conditions
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-04-04
- Last Posted Date
- 2008-04-04
- Lead Sponsor
- Par Pharmaceutical, Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT00653419
- Locations
- ๐จ๐ฆ
Phoenix International Life Sciences, Inc., St-Laurent, Quebec, Canada
Bioavailability Study of Doxycycline Monohydrate Capsules and Monodox Under Fasting and Fed Conditions
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-04-04
- Last Posted Date
- 2017-09-26
- Lead Sponsor
- Par Pharmaceutical, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT00652704
- Locations
- ๐จ๐ฆ
Anapharm, Inc., Sainte-Foy, Quebec, Canada
Effect of Renal Impairment on the Pharmacokinetics, and Safety of Megestrol Acetate Concentrated Suspension
Phase 1
Terminated
- Conditions
- Interventions
- First Posted Date
- 2008-03-18
- Last Posted Date
- 2016-10-17
- Lead Sponsor
- Par Pharmaceutical, Inc.
- Target Recruit Count
- 7
- Registration Number
- NCT00637403
- Locations
- ๐บ๐ธ
SFBC International, Miami, Florida, United States
Treatment of Cancer-anorexia Using Megestrol Acetate Concentrated Suspension in Lung or Pancreatic Cancer Patients
Phase 3
Terminated
- Conditions
- Interventions
- First Posted Date
- 2008-03-18
- Last Posted Date
- 2016-06-23
- Lead Sponsor
- Par Pharmaceutical, Inc.
- Target Recruit Count
- 5
- Registration Number
- NCT00637728
- Locations
- ๐บ๐ธ
Innovative Medical Research of South Florida, Inc, Miami, Florida, United States
๐บ๐ธWestern Maryland Health System, Cumberland, Maryland, United States
๐บ๐ธLowcountry Hematology & Oncology, PA, Mt. Pleasant, South Carolina, United States
Treatment of Cancer-associated Anorexia Using Megestrol Acetate Concentrated Suspension
Phase 3
Terminated
- Conditions
- Interventions
- First Posted Date
- 2008-03-18
- Last Posted Date
- 2016-05-02
- Lead Sponsor
- Par Pharmaceutical, Inc.
- Target Recruit Count
- 4
- Registration Number
- NCT00637806
- Locations
- ๐บ๐ธ
Pacific Cancer Medical Center, Inc., Anaheim, California, United States
๐บ๐ธSummit Oncology Associates, Inc., Akron, Ohio, United States
๐บ๐ธFour Seasons Hospice and Paliative Care, Flat Rock, North Carolina, United States
ยฉ Copyright 2024. All Rights Reserved by MedPath